Pharmchem Stock Analysis
| PCHM Stock | USD 3.05 0.00 0.00% |
PharmChem is overvalued with Real Value of 2.71 and Hype Value of 3.05. The main objective of PharmChem pink sheet analysis is to determine its intrinsic value, which is an estimate of what PharmChem is worth, separate from its market price. There are two main types of PharmChem's stock analysis: fundamental analysis and technical analysis.
The PharmChem pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
PharmChem |
PharmChem Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PharmChem recorded a loss per share of 0.35. The entity last dividend was issued on the 7th of February 2023. The firm had 1:6 split on the 5th of November 2020. PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.The quote for PharmChem is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about PharmChem contact the company at 855-458-4100 or learn more at https://www.pharmchek.com.PharmChem Investment Alerts
| PharmChem generated a negative expected return over the last 90 days | |
| The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity. | |
| PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M. |
PharmChem Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 17.55 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PharmChem's market, we take the total number of its shares issued and multiply it by PharmChem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.PharmChem Profitablity
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.Technical Drivers
As of the 23rd of December, PharmChem holds the Variance of 8.58, coefficient of variation of (1,356), and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PharmChem, as well as the relationship between them. Please check PharmChem market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if PharmChem is priced some-what accurately, providing market reflects its current price of 3.05 per share. Given that PharmChem has information ratio of (0.08), we recommend you to check out PharmChem's recent market performance to make sure the company can sustain itself at a future point.PharmChem Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PharmChem middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PharmChem. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
PharmChem Outstanding Bonds
PharmChem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PharmChem uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PharmChem bonds can be classified according to their maturity, which is the date when PharmChem has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| PHARMACIA P 66 Corp BondUS71713UAW27 | View | |
| PHARMACIA P 675 Corp BondUS71713UAT97 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
PharmChem Predictive Daily Indicators
PharmChem intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PharmChem pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PharmChem Forecast Models
PharmChem's time-series forecasting models are one of many PharmChem's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PharmChem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About PharmChem Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how PharmChem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PharmChem shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as PharmChem. By using and applying PharmChem Pink Sheet analysis, traders can create a robust methodology for identifying PharmChem entry and exit points for their positions.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding PharmChem to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.